Chondrosarcoma epidemiology and demographics

Chondrosarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Chondrosarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Chondrosarcoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Chondrosarcoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chondrosarcoma epidemiology and demographics
CDC on Chondrosarcoma epidemiology and demographics
Chondrosarcoma epidemiology and demographics in the news
Blogs on Chondrosarcoma epidemiology and demographics
Directions to Hospitals Treating Chondrosarcoma
Risk calculators and risk factors for Chondrosarcoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

Chondrosarcomas are malignant cartilaginous tumors that account for 20-27% of all primary malignant bone tumors. Chondrosarcoma is the second most common malignant primary tumor of bone.

Age

• Chondrosarcoma is most frequently diagnosed in patients in their 4th and 5th decades of life.

Gender

• Men are slightly more affected with chondrosarcoma than women.

References

Template:WikiDoc Sources